Why Might Thiazolidinediones Increase Exercise Capacity in Patients With Type 2 Diabetes?
- 1 December 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (12) , 2975-2977
- https://doi.org/10.2337/diacare.28.12.2975
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Rosiglitazone Improves Exercise Capacity in Individuals With Type 2 DiabetesDiabetes Care, 2005
- AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exerciseBiochemical and Biophysical Research Communications, 2004
- Metabolic and hormonal interactions between muscle and adipose tissueProceedings of the Nutrition Society, 2004
- AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndromeNature Reviews Drug Discovery, 2004
- Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial CellsJournal of Biological Chemistry, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Role of Adiponectin in Preventing Vascular StenosisJournal of Biological Chemistry, 2002
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysJournal of Biological Chemistry, 2002
- Lipotoxic DiseasesAnnual Review of Medicine, 2002
- Nutritive and non‐nutritive blood flow: rest and exerciseActa Physiologica Scandinavica, 2000